Mylan NV on Wednesday named Chairman Robert Coury to the role of executive chairman to help steer the drugmaker through the coronavirus pandemic and its delayed merger with Pfizer Inc’s off-patent branded drug unit, Upjohn.
Source:: Reuters – Business News
